Skip to main content

Cardiomyopathy clinical trials at UCSF

17 in progress, 10 open to eligible people

Cardiomyopathy is a disease that affects the heart muscle. UCSF is studying different treatments for people with hypertrophic cardiomyopathy, including a trial using a drug called Mavacamten. Another study is testing the safety of a new medicine called EDG-7500. UCSF is also looking at how exercise affects those with non-obstructive hypertrophic cardiomyopathy.

Showing trials for

Our lead scientists for Cardiomyopathy research studies include .

Last updated: